As per announcement on 20/04/20. "Holista and GICC LLC have issued instructions to commence further tests on Path-Away® to assess its
efficacy against COVID-19 via the more rigorous direct inoculation method. This additional testing is being conducted at Biosafety Laboratory approved by the Centers for Disease Control (“CDC” ) of the United States. Results are expected to be released as soon as the testing procedure is completed based on the current work schedule." Now having just read that again it could be taken two ways. First they are testing directly against COVID-19 or they are doing a different sort of test against the Feline Coronavirus to just test efficiency. Like a lot of their announcements it's written badly which creates confusion. I think management could probably run a corner store but they are not up to task for an ASX listed public company.
- Forums
- ASX - By Stock
- HCT
- HCT CHART upward indication
HCT CHART upward indication, page-788
-
-
- There are more pages in this discussion • 66 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HCT (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.0¢ |
Change
-0.002(9.09%) |
Mkt cap ! $5.576M |
Open | High | Low | Value | Volume |
2.2¢ | 2.2¢ | 2.0¢ | $3.316K | 156.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 37641 | 2.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.5¢ | 12359 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 37641 | 0.020 |
1 | 9829 | 0.017 |
1 | 200000 | 0.010 |
1 | 45000 | 0.005 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.025 | 12359 | 1 |
0.028 | 679999 | 3 |
0.029 | 128000 | 3 |
0.030 | 112000 | 2 |
0.039 | 668200 | 2 |
Last trade - 10.52am 13/09/2024 (20 minute delay) ? |
Featured News
HCT (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online